SCHEMBL7185464

SCHEMBL7185464

CCCOc1c(C=CC(=O)c2ccc(N)cc2)cc(C(C)(C)C)c(O)c1C(C)(C)C

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCG2 Q9UNQ0 2/20 0.44
CTSL P07711 1/20 0.43
CTSB P07858 1/20 0.43
DPP4 P27487 3/20 0.42
TNFRSF1A P19438 1/20 0.41
CYP1B1 Q16678 3/20 0.41
PTPN1 P18031 3/20 0.41
CYP1A1 P04798 2/20 0.41
CA1 P00915 2/20 0.40
CA2 P00918 2/20 0.40
KRAS P01116 1/20 0.40
BCHE P06276 1/20 0.38
CYP3A4 P08684 1/20 0.38
MEN1 O00255 1/20 0.37
NPC1 O15118 1/20 0.37
ALDH1A1 P00352 1/20 0.37
LMNA P02545 1/20 0.37
MAPT P10636 1/20 0.37
NFKB1 P19838 1/20 0.37
HTT P42858 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7185461 1.00 ABCG2 (0.44) ABCG2CTSLCTSBDPP4TNFRSF1A
SCHEMBL7182489 0.92 CTSL (0.45) ABCG2CTSLCTSBDPP4TNFRSF1A
SCHEMBL7182485 0.92 CTSL (0.45) ABCG2CTSLCTSBDPP4TNFRSF1A
SCHEMBL7184229 0.92 ABCG2 (0.54) ABCG2CTSLCTSBDPP4TNFRSF1A
SCHEMBL7184224 0.92 ABCG2 (0.54) ABCG2CTSLCTSBDPP4TNFRSF1A
SCHEMBL7192357 0.88 CTSL (0.42) ABCG2CTSLCTSBDPP4CYP1B1
SCHEMBL7182567 0.88 ABCG2 (0.43) ABCG2CTSLCTSBDPP4TNFRSF1A
SCHEMBL7192360 0.88 CTSL (0.42) ABCG2CTSLCTSBDPP4CYP1B1
SCHEMBL7182572 0.88 ABCG2 (0.43) ABCG2CTSLCTSBDPP4TNFRSF1A
SCHEMBL7185844 0.86 PTPN1 (0.48) ABCG2CTSLCTSBDPP4CYP1B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6603046-B1 The invention is drawn to novel bis-aromatic a, beta -unsaturated ketones. The compounds are useful in the treatment and prophylaxis of diseases caused by parasites or bacteria. LICA PHARMACEUTICALS A/S (DK) 2003-08-05 US disclosed
EP-0634927-B1 TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES, OR BACTERIA LICA PHARMACEUTICALS AS (DK) 2001-07-04 EP disclosed
EP-0634927-A1 TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES, OR BACTERIA STATENS SERUMINSTITUT (DK) 1995-01-25 EP disclosed
WO-1993017671-A1 TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES, OR BACTERIA STATENS SERUMINSTITUT (DK) 1993-09-16 WO disclosed